Back
Novo Nordisk A/S 10K Form
Sell
30
NVO
Novo Nordisk A/S
Last Price:
$49.50
Seasonality Move:
10.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVO News And Ratings
See the #1 stock for the next 7 days that we like better than NVO
NVO Financial Statistics
Sales & Book Value
| Annual Sales: | $46.7B |
|---|---|
| Cash Flow: | $-5.4B |
| Price / Cash Flow: | 49.49 |
| Annual Sales: | $6.87 |
| Price / Book: | 9.41 |
Profitability
| EPS (TTM): | 3.46800 |
|---|---|
| Net Income (TTM): | $15.4B |
| Gross Margin: | $37.5B |
| Return on Equity: | 62.44% |
| Return on Assets: | 20.47% |
Novo Nordisk A/S Earnings Forecast
Key Novo Nordisk A/S Financial Ratios
-
The Gross Profit Margin over the past 46 years for NVO is 80.34%.
-
The Selling, General & Administrative Expenses for NVO have been equal to 22.74% of Gross Profit Margin.
-
The Research & Development expenses have been 14.63% of Revenue.
-
The Interest Expense is 4.12% of Operating Income.
-
The Net Earning history of NVO is 33.14% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 35 years.
Novo Nordisk A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVO |
| CUSIP: | 670100 |
| Website: | novonordisk.com |
Debt
| Debt-to-Equity Ratio: | 0.67 |
|---|---|
| Current Ratio: | 0.8 |
| Quick Ratio: | 0.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.05 |
|---|---|
| Forward P/E Ratio: | 13.93 |
NVO Technical Analysis vs Fundamental Analysis
Sell
30
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a SellThe current Novo Nordisk A/S [NVO] share price is $48.93. The Score for NVO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.